Azitromicin — разлика између измена

Садржај обрисан Садржај додат
м Бот: уклоњен дуплирани параметар; козметичке измене
м →‎top: . using AWB
Ред 9:
| imagename =
| drug_name = Azitromicin
| caption =
 
<!-- Clinical data -->
Ред 59:
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 2955
| synonyms =
 
<!-- Chemical data -->
Ред 80:
| sec_combustion =
}}
'''Azitromicin''' je polusintetički [[makrolid|makrolidni antibiotik]] azalidne klase. Poput drugih makrolidnih antibiotika, azitromicin inhibira bakterijsku proteinsku sintezu vezivanjem za 50S [[ribozom]]alnu podjedinicu bakterijskog 70S ribozoma.<ref>-{Noedl H, Krudsood S, Chalermratana K, Silachamroon U, Leowattana W, Tangpukdee N, Looareesuwan S, Miller RS, Fukuda M, Jongsakul K, Sriwichai S, Rowan J, Bhattacharyya H, Ohrt C, Knirsch C: Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand. Clin Infect Dis. 2006 Nov 15;43(10):1264-71. Epub 2006 Oct 12. [[PubMed|PMID]] [http://www.ncbi.nlm.nih.gov/pubmed/17051490 17051490]}-</ref><ref>{{cite journal |title = DrugBank 3.0: a comprehensive resource for omics research on drugs |author vauthors= Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS |journal = Nucleic Acids Res. |year = 2011 |volume = 39 |issue = Database issue |pages = D1035-41 | pmid =21059682}}</ref><ref>{{cite journal |title = DrugBank: a knowledgebase for drugs, drug actions and drug targets |author = Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M (Nucleic Acids Res) |year = 2008 |volume = 36 |issue = Database issue |pages = D901-6 |pmid = 18048412}}</ref>
 
== Reference ==
Преузето из „https://sr.wikipedia.org/wiki/Azitromicin